ChromaCure, a recent spin-off of the ULB and Professor Cédric Blanpain’s laboratory, developing small molecule therapeutics to treat cancer,is looking for a Research Assistant. Interested? Please find the job offering and contact details here.
Iteos Therapeutics developing novel cancer immunotherapies, announced the first cohort of patients has been dosed in its Phase 1/1b study with EOS100850, the Company’s investigational A2A receptor antagonist and lead program candidate. Discover the press release here.Read more